Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877) has released an update.
Shanghai Junshi Biosciences Co., Ltd. has announced that their Board of Directors will meet on August 30, 2024, to review and approve the company’s interim financial results for the first half of the year. This meeting is expected to provide insights into the company’s performance and strategic direction. Shareholders and potential investors should anticipate updates following this significant board meeting.
For further insights into HK:1877 stock, check out TipRanks’ Stock Analysis page.
